• SENSEX 80,710.76
    -7.25 (--0.01%)
  • BANKNIFTY 54,114.55
    39.10 (+0.07%)
  • N S D L
    1,298.70 1,425.00(%)
  • Ola Electric
    59.38 39.58(%)
  • Netweb Technol.
    3,180.10 3,180.10(%)
  • Indus Towers
    341.75 444.45(%)
  • Vodafone Idea
    7.45 15.22(%)
  • Moschip Tech.
    258.25 279.00(%)
  • Godfrey Phillips
    11,150.00 11,462.00(%)
  • Vimta Labs
    902.85 902.85(%)
  • G M D C
    515.00 515.00(%)
  • Fiem Industries
    2,005.00 1,156.00(%)
  • One Mobikwik
    309.00 698.30(%)
  • Brainbees Solut.
    407.80 734.25(%)
  • Apollo Micro Sys
    298.65 88.10(%)
  • Avantel
    180.20 191.01(%)
  • Swiggy
    440.00 617.00(%)
  • TCS
    3,029.50 2,992.05(%)
  • Eternal Ltd
    334.40 334.40(%)
  • L&T Finance Ltd
    232.85 232.85(%)
  • Reliance Industr
    1,380.80 1,551.00(%)
  • Kross Ltd
    235.00 271.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Medico Remedies Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 71781.0
  • ISIN : INE630Y01024
39.47 0 (-0.10%)
  • As on 07 Sep 2025 (EOD)

  • Today’s Low

    38.82

  • Today’s High

    39.91

  • Open

    39.15

  • Perv Close

    39.51

  • 52W Low

    37.18

  • 52W High

    79.83

Key Indicators

  • P/E(TTM)

    31.38

  • Mar.Cap (₹Cr.)

    327.54

  • Div & Yield %

    0.00

  • Book Value(₹)

    7.53

  • Debt-Equity Ratio

    -0.10

  • AGM Date

    05-Sep-2025

  • EPS

    1.25

  • P/E Ratio

    31.38

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    327.54

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    16.60

  • BV (₹)

    7.50

  • Sales( ₹ in Cr.)

    150.94

  • NP (in Cr.)

    10.09

  • NP Var(%)

    22.0

  • Div%

    0.0

  • CPS (₹)

    1.60

  • EPS (₹)

    1.20

  • Traded Value (₹ in Lakhs)

    325.46

  • 52 Week High

    79.83

  • 52 Week Low

    37.18

  • Price BSE

    39.0

  • Price NSE

    39.00

  • Market Capital( in Cr.)

    325.46

  • P/C Ratio

    24.70

  • P/E Ratio

    32.10

  • Price Vs.BV

    1.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 150.94 144.92 140.44 121.02 122.39 88.64
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 150.94 144.92 140.44 121.02 122.39 88.64
Other Income 2.69 2.13 3.95 2.03 1.03 2.10
Stock Adjustments 5.16 -2.04 1.18 0.26 -1.54 3.63
Total Income 158.79 145.01 145.57 123.31 121.88 94.37
EXPENDITURE :            
Raw Materials 113.49 107.87 106.05 87.55 90.69 70.81
Power and Fuel Cost 2.92 2.55 2.47 2.29 1.91 1.83
Employee Cost 6.28 5.92 5.68 5.41 4.50 3.83
Other Manufacturing Expenses 7.72 6.25 5.48 6.44 5.25 4.56
Selling and Administration Expenses 10.84 6.49 11.92 11.20 10.60 7.72
Miscellaneous Expenses -0.15 0.89 0.40 1.05 2.66 0.68
Employee Benefit Expenses 6.28 5.92 5.68 5.41 4.50 3.83
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 141.10 129.97 132.00 113.95 115.61 89.42
Operating Profit 17.69 15.03 13.57 9.36 6.27 4.94
Interest 1.16 0.82 0.75 0.66 0.92 1.06
Gross Profit 16.53 14.21 12.82 8.70 5.35 3.88
Depreciation 3.03 2.88 2.72 2.22 1.65 1.66
Profit Before Tax 13.50 11.33 10.10 6.48 3.70 2.22
Current Tax 3.80 3.17 2.50 1.79 1.06 0.57
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.39 -0.12 0.36 -0.12 0.05 0.01
Reported Net Profit 10.09 8.29 7.24 4.81 2.59 1.63
Extraordinary Items 0.00 0.00 0.00 -0.03 0.00 0.00
Adjusted Net Profit 10.09 8.29 7.24 4.84 2.59 1.63
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 32.21 23.92 16.67 11.86 9.91 8.28
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 42.30 32.21 23.92 16.67 12.50 9.91
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 1.22 1.00 0.87 2.90 6.24 3.93
Earnings Per Share(Adj)-Unit Curr 1.22 1.00 0.87 0.58 0.31 0.20
Book Value 7.53 6.31 5.28 22.04 78.22 71.98
Book Value(Adj)-Unit Curr 7.53 6.31 5.28 4.41 3.91 3.60

Shareholding Pattern

  • Promoter Group

    62.59%

  • Public Share Holding

    37.41%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 51,937,145 62.59 51,937,145 6
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 51,937,145 62.59 51,937,145 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 58,499 0.07 58,499 2
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 11,279 0.01 11,279 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 69,778 0.08 69,778 3
2] Non Institution
Bodies Corporate 3,946,577 4.76 3,946,177 69
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 268,663 0.32 268,663 108
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 6,903,480 8.32 6,902,680 194
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 6,802,867 8.20 6,802,867 24
Individuals holding nominal share capital up to Rs. 1 lakh 12,112,888 14.60 12,111,288 16,062
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 30,977,077 37.33 30,974,277 16,465
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 82,984,000 100.00 82,981,200 16,474

Company Background

Medico Remedies LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Medico Remedies Ltd
  • BSE Code : 71781.0
  • ISIN : INE630Y01024

  • Incorporation Year

    1994

  • Registered Office

    1105/1106 11-Flr Hubtown Solar
    N S Phadke Marg Andheri East, Mumbai,
    Maharashtra-400069

  • Telephone

    91-22-2670 1055/66

  • FAX

  • Chairman

    Haresh Mehta

  • Managing Director

    Harshit Mehta

  • Company Secretary

  • Auditor

    V J Shah & Co

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    Cameo Corporate Services Ltd
    Subramanian Building,
    1ST Floor No 1,Club House Road
    Mumbai - Chennai - 600002

Medico Remedies Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Medico Remedies 39.22 153.63 150.94 31.38 21.31
Abbott India 31,179.05 6,684.73 6,409.15 45.62 44.95
Astrazeneca Phar 9,088.15 1,756.92 1,716.29 123.92 32.94
P & G Health Ltd 6,465.40 944.52 934.17 35.70 40.23
Glaxosmi. Pharma 2,770.30 3,866.05 3,723.49 49.82 58.72
Cipla 1,553.30 20,029.57 19,044.85 23.21 21.40
Amrutanjan Healt 769.30 469.50 451.82 40.79 21.89
Guj. Themis Bio. 383.80 152.47 150.80 93.84 27.21
Fermenta Biotec. 334.60 442.21 430.53 11.10 17.61
Bliss GVS Pharma 156.00 703.42 667.20 23.32 9.16
Ambalal Sarabhai 32.39 19.33 4.04 16.96 2.10